Similar to GLUT1 overexpression in cancer, folate receptor α (FR-α) has been demonstrated to be overexpressed in an estimated 40% of human cancers, which make it possible to utilize folate receptor to enhance cellular uptake and improve cancer selectivity (Low & Kularatne, 2009). This evidence concerns the gene SLC2A1 and cancer.